IOBT To Report Melanoma Trial Data In Q3, NPCE Eyes 15-20% Revenue Growth For 2025, DXR On Watch

The following are some of the healthcare sector stocks to watch today.

Daxor Corp. (DXR), a blood volume measurement technology company, revealed that it has had a successful 2024 and an even stronger start to 2025, driven by a series of strategic advancements in product development, revenue growth, and key acquisitions. Its revenue for 2024 jumped 116.5% compared to 2023, reflecting robust demand for its diagnostic systems, a record for the company.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com